Company Analysis

Rigel Pharmaceuticals, Inc. (RIGL)

Nasdaq: RIGL · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2000
Grade6.4
◀ Past 5.0● Present 7.6▶ Future 6.3

Who runs Rigel Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Rodriguez Raul R
CEO, President. First filing Jan 2006, latest Sep 3, 2026, 5 filings in all.
Officers reporting now
6
of 12 people with a filing in the last fifteen months
Directors reporting now
6
29 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Rodriguez Raul RCEO, PresidentJan 2006Sep 3, 2026none
Schorno Dean LEVP & Chief Financial OfficerJun 2018Sep 3, 2026none
Santos David AEVP, Chief Commercial OfficerAug 2020Sep 3, 2026none
Furey Raymond J.EVP, GC, CCO & Corp SecDec 2022Sep 3, 2026none
Hannah Alison L.EVP, Chief Medical OfficerMay 2021Jul 10, 2026none
Rojkjaer LisaEVP, Chief Medical OfficerMar 2024Jun 22, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Ali-Jackson KamildirectorDec 2021Jun 24, 20262 · $200,000
Frohlich Mark WdirectorMar 2025May 19, 2026none
Lapointe Anthony GreggdirectorNov 2017May 19, 2026none
Miller Michael PatrickdirectorFeb 2026May 19, 2026none
Moos Walter HdirectorMay 2006May 19, 20261 · $100,000
Wasman JanedirectorApr 2019May 19, 2026none
Earlier names on the record17, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton RIGL · research, not advice